ASX/MSB (ASX/MSB)

Australian Securities Exchange: ASX/MSB · AUD

A$2.32

+0.44 (+23.4%)· Recorded snapshot

Market cap	3B
Revenue (ttm)	173.8M
Net income (ttm)	-83.1M
EPS (ttm)	-A$0.06
Shares out	1.3B
Volume	13,592,793
Beta	0.86

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 173.8M
Net income (ttm): -83.1M
EPS (ttm): -A$0.06
Market cap: 3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-9.9

P25 n/aP50 n/aP75 n/a

ROIC-4.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/MSB indicators

Market & fundamental data

Available fields

197

Groups with data

Currency

USD

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-17
Employees	108
Employees change	27
Employees growth	33.33%
Enterprise value	AUD 3B
Exchange	Australian Securities Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2004
In index	ASX200
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU000000MSB8
Last earnings date	2026-08-26
Last refreshed	2026-10-29
Market cap	AUD 3B
Next earnings date	2026-11-17
Price	AUD 2.32
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	asx/MSB
Website	https://www.mesoblast.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-2.77%
EV/Sales	17.53x
FCF / EV yield	-2.12%
FCF yield	-2.14%
Industry forward P/E	28.51x
P/B ratio	3.67x
P/S ratio	17.33x
Price / tangible book value	1,024.15x
Sector forward P/E	33.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-42.62%
EBITDA margin	-37.09%
Gross margin	80.02%
Operating margin	-42.62%
Pretax margin	-47.31%
Profit margin	-47.82%
Profit per employee	AUD -769,595
Revenue per employee	AUD 1.6M
ROA	-4.11%
ROA (5Y)	-5.71%
ROCE	-7.41%
ROE	-9.86%
ROE (5Y)	-16.01%
ROIC	-4.51%
SBC / revenue	12.37%
Tax / revenue	0.51%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	4
EPS growth years	1
Gross profit growth (Q)	6,432.93%
Net income growth quarters	4
Net income growth years	1
Revenue growth	599.21%
Revenue growth (Q)	390.73%
Revenue growth (QoQ)	34.21%
Revenue growth 10Y	10.95%
Revenue growth 3Y	152.15%
Revenue growth 5Y	74.49%
Revenue growth quarters	8
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -1.2M
Depreciation and amortization	AUD 9.4M
EBIT	AUD -74.1M
EBITDA	AUD -64.5M
EPS	AUD -0.06
FCF per share	AUD -0.05
Financing cash flow	AUD -22.2M
Free cash flow	AUD -64.6M
Free cash flow minus SBC	AUD -86.1M
Gross profit	AUD 139.1M
Income taxes	AUD 886,092
Investing cash flow	AUD -1.5M
Net borrowing	AUD -8.4M
Net cash flow	AUD -84.8M
Net income	AUD -83.1M
Operating cash flow minus SBC	AUD -84.9M
Operating income	AUD -74.1M
Revenue	AUD 173.8M
Stock-based compensation	AUD 21.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.13
Book value per share	AUD 0.63
Debt / equity	0.22
Goodwill	AUD 191M
Interest coverage	-2.58
Long-term assets	AUD 836.9M
Long-term liabilities	AUD 180.6M
Net cash (debt)	AUD -35.3M
Net cash / market cap	-1.17%
Net debt / equity	0.04
Piotroski F-Score	4
Property, plant and equipment	AUD 11.4M
Shareholders' equity	AUD 821.6M
Tangible book value	AUD 2.9M
Tangible book value per share	AUD 0.00
Total assets	AUD 1.1B
Total cash	AUD 148.8M
Total debt	AUD 184.1M
Total liabilities	AUD 295.9M
WACC	9.17%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.15
Current assets	AUD 280.6M
Current liabilities	AUD 115.3M
Current ratio	2.43
Inventory turnover	0.95
Net working capital	AUD 39.2M
Quick ratio	1.98
Working capital	AUD 168.2M
Working capital turnover	1.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-7.21%
Shareholder yield	-7.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	100%
10Y return CAGR	7.86%
10Y total return	113.08%
150-day SMA	AUD 2.14
15Y price change	-72.54%
15Y return CAGR	-7.87%
15Y total return	-70.75%
1D price change	23.4%
1M price change	13.73%
1M total return	13.73%
1W price change	26.78%
1W total return	26.78%
1Y price change	-9.38%
1Y return CAGR	-9.38%
1Y total return	-9.38%
20-day SMA	AUD 1.94
200-day SMA	AUD 2.18
20Y price change	60.55%
20Y return CAGR	2.72%
20Y total return	71.05%
3M price change	12.62%
3M total return	12.62%
3Y price change	535.62%
3Y return CAGR	88.53%
3Y total return	570.38%
50-day SMA	AUD 2.11
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 3.31
52-week high date	2026-01-09
52-week low	AUD 1.74
52-week low date	2026-10-16
5Y price change	45.91%
5Y return CAGR	9.01%
5Y total return	53.89%
6M price change	7.91%
6M total return	7.91%
All-time high	AUD 10.04
All-time high date	2011-10-24
All-time low	AUD 0.26
All-time low date	2024-02-05
Average true range (ATR)	AUD 0.13
Average volume	4.5M
Beta (1Y)	0.7
Beta (2Y)	0.42
Beta (5Y)	0.86
Change from 52-week high	-29.91%
Change from 52-week low	33.72%
Change from all-time high	-76.89%
Change from all-time low	809.8%
Change from open	19.28%
Day's gap	3.46%
Dollar volume	AUD 31.5M
High price	AUD 2.38
Low price	AUD 1.95
Monthly RSI	55.35
Open price	AUD 1.95
Position in 52-week range	86.21%
Previous close	AUD 1.88
Price vs 150-day SMA	8.61%
Price vs 20-day SMA	19.53%
Price vs 200-day SMA	6.37%
Price vs 50-day SMA	9.9%
Relative volume	3.1
RSI	66.17
Sharpe ratio	0.1
Sharpe ratio (3Y)	1.05
Sharpe ratio (5Y)	0.46
Sortino ratio	0.25
Sortino ratio (3Y)	2.28
Sortino ratio (5Y)	0.86
Volume	13.6M
Weekly RSI	54.07
YTD price change	-14.71%
YTD total return	-14.71%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	830.6M
Shares change (QoQ)	0.44%
Shares change (YoY)	7.21%
Shares held by insiders	34.17%
Shares held by institutions	26.1%
Shares outstanding	1.3B

Deeper analysis on ASX/MSB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/MSB report

Is a complete ASX/MSB research report available?

No complete published report is available for asx/MSB (ASX/MSB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/MSB (ASX/MSB)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/MSB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/MSB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/MSB

Frequently asked questions